Together, our findings demonstrate that LJ3402 preserves liver function during aging by improving mitochondrial function and suppressing cellular senescence through the PGC‐1α–SIRT1–p53 pathway, supporting LJ3402 as a potential preventive strategy for age‐related metabolic disorders. This evidence concerns the gene TP53 and metabolic disease.